Rose Ann Padua

4.5k total citations
104 papers, 3.1k citations indexed

About

Rose Ann Padua is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Rose Ann Padua has authored 104 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 53 papers in Hematology and 23 papers in Genetics. Recurrent topics in Rose Ann Padua's work include Acute Myeloid Leukemia Research (49 papers), Retinoids in leukemia and cellular processes (28 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Rose Ann Padua is often cited by papers focused on Acute Myeloid Leukemia Research (49 papers), Retinoids in leukemia and cellular processes (28 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Rose Ann Padua collaborates with scholars based in United Kingdom, France and United States. Rose Ann Padua's co-authors include Nigel Barrass, David C. Hughes, David Oscier, G A Currie, S. Ridge, Christine Chomienne, A Jacobs, Allan J. Jacobs, Sharon L. McKenna and J. A. Holmes and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Rose Ann Padua

100 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rose Ann Padua United Kingdom 32 1.6k 1.2k 926 480 464 104 3.1k
Virginie Penard‐Lacronique France 23 1.4k 0.9× 977 0.8× 829 0.9× 573 1.2× 592 1.3× 44 2.8k
Mark Blick United States 28 1.0k 0.7× 830 0.7× 999 1.1× 343 0.7× 589 1.3× 55 2.8k
Kensuke Kojima Japan 29 1.8k 1.1× 959 0.8× 1.1k 1.2× 327 0.7× 444 1.0× 135 2.9k
N Feller Netherlands 21 975 0.6× 1.1k 0.9× 1.2k 1.3× 413 0.9× 235 0.5× 56 2.5k
Hiroya Asou Japan 29 2.3k 1.5× 869 0.7× 1.2k 1.3× 383 0.8× 322 0.7× 70 3.9k
Jan Jacob Schuringa Netherlands 39 2.1k 1.3× 1.8k 1.5× 884 1.0× 918 1.9× 581 1.3× 147 4.1k
Tetsuzo Tauchi Japan 30 1.6k 1.0× 1.5k 1.2× 621 0.7× 442 0.9× 911 2.0× 146 3.1k
Eugenio Gallo Italy 27 687 0.4× 711 0.6× 548 0.6× 489 1.0× 393 0.8× 94 2.3k
Roberta Riccioni Italy 23 1.4k 0.9× 812 0.7× 523 0.6× 461 1.0× 234 0.5× 45 2.1k
Dario Ferrero Italy 25 872 0.6× 1.0k 0.8× 472 0.5× 338 0.7× 488 1.1× 92 2.0k

Countries citing papers authored by Rose Ann Padua

Since Specialization
Citations

This map shows the geographic impact of Rose Ann Padua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Ann Padua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Ann Padua more than expected).

Fields of papers citing papers by Rose Ann Padua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose Ann Padua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Ann Padua. The network helps show where Rose Ann Padua may publish in the future.

Co-authorship network of co-authors of Rose Ann Padua

This figure shows the co-authorship network connecting the top 25 collaborators of Rose Ann Padua. A scholar is included among the top collaborators of Rose Ann Padua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose Ann Padua. Rose Ann Padua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alex, Ansu Abu, Saravanan Ganesan, Nithya Balasundaram, et al.. (2018). Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis. Frontiers in Immunology. 9. 1357–1357. 16 indexed citations
2.
Zassadowski, Fabien, Kateřina Pokorná, Fabien Guidez, et al.. (2015). Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent. Leukemia. 29(12). 2277–2284. 21 indexed citations
3.
Pokorná, Kateřina, Martine Chopin, N Balitrand, et al.. (2012). Tracking the extramedullary PML-RARα-positive cell reservoirs in a preclinical model: Biomarker of long-term drug efficacy. Molecular and Cellular Probes. 27(1). 1–5. 4 indexed citations
4.
Fan, Alice C., Debabrita Deb-Basu, Mathias Orban, et al.. (2009). Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. Nature Medicine. 15(5). 566–571. 86 indexed citations
5.
Rassool, Feyruz V., Terry J. Gaymes, Nader Omidvar, et al.. (2007). Reactive Oxygen Species, DNA Damage, and Error-Prone Repair: A Model for Genomic Instability with Progression in Myeloid Leukemia?. Cancer Research. 67(18). 8762–8771. 130 indexed citations
6.
Gaymes, Terry J., Rose Ann Padua, Marika Pla, et al.. (2006). Histone Deacetylase Inhibitors (HDI) Cause DNA Damage in Leukemia Cells: A Mechanism for Leukemia-Specific HDI-Dependent Apoptosis?. Molecular Cancer Research. 4(8). 563–573. 77 indexed citations
7.
Plenchette, Stéphanie, Séverine Cathelin, Cédric Rébé, et al.. (2004). Translocation of the inhibitor of apoptosis protein c-IAP1 from the nucleus to the Golgi in hematopoietic cells undergoing differentiation: a nuclear export signal-mediated event. Blood. 104(7). 2035–2043. 50 indexed citations
8.
Padua, Rose Ann & Christine Chomienne. (2004). Use of animal models for the treatment of leukemias: Efficacy of DNA vaccination combined with ATRA.. PubMed. 4(20). 41–4. 5 indexed citations
9.
McKenna, Sharon L. & Rose Ann Padua. (1997). MULTIDRUG RESISTANCE IN LEUKAEMIA. British Journal of Haematology. 96(4). 659–674. 64 indexed citations
10.
Bowen, David, Rose Ann Padua, Alan K. Burnett, Carlos M. DeCastro, & Russel E. Kaufman. (1993). Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots.. PubMed. 7(11). 1883–5. 10 indexed citations
11.
Baines, Paul, et al.. (1992). Multidrug resistance in leukaemia. Baillière s Clinical Haematology. 5(4). 943–960. 12 indexed citations
12.
Cachia, P G, et al.. (1992). Clonal lymphocytes are detectable in only some cases of MDS. British Journal of Haematology. 81(3). 346–352. 73 indexed citations
14.
Holmes, Jordan A., et al.. (1991). Frequency of carriers of cystic fibrosis gene among patients with myeloid malignancy and melanoma.. BMJ. 302(6779). 760–761. 20 indexed citations
15.
Padua, Rose Ann, David C. Hughes, John Gow, et al.. (1989). RAS Mutations in Preleukaemias. Hämatologie und Bluttransfusion. 32. 250–254. 2 indexed citations
16.
Nimmo, Elaine R., Rose Ann Padua, David C. Hughes, et al.. (1989). Confirmation and refinement of the localisation of the c-MEL locus on chromosome 19 by physical and genetic mapping. Human Genetics. 81(4). 382–384. 5 indexed citations
17.
Lemoine, Nicholas R., Christine J. Farr, David C. Hughes, et al.. (1988). Activated ras oncogenes in human thyroid cancers.. PubMed. 48(16). 4459–63. 182 indexed citations
18.
Padua, Rose Ann, David C. Hughes, Jeff Gow, et al.. (1988). RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation.. PubMed. 2(8). 503–10. 126 indexed citations
19.
Löhler, Jürgen, et al.. (1987). Retrovirus-Induced Malignant Histiocytosis in Mice: A Model for the Human Disease. Hämatologie und Bluttransfusion. 31. 448–449. 1 indexed citations
20.
Spurr, Nigel K., David C. Hughes, Peter N. Goodfellow, J. David Brook, & Rose Ann Padua. (1986). Chromosomal assignment of c-MEL, a human transforming oncogene, to chromosome 19 (p13.2-q13.2). Somatic Cell and Molecular Genetics. 12(6). 637–640. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026